코어라인소프트

384470KOSDAQ소프트웨어 개발 및 공급업

35.0 / 100

Reference Date: 2026-04-13

Financial Score7.0 / 40

News Sentiment15.0 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Declined 7.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CoreLineSoft is an AI-based medical imaging software company established in 2012, specializing in developing and selling products like the AVIEW series, which assist in diagnosing lung cancer, COPD, and coronary artery calcification through thoracic CT image analysis. The company has expanded into global markets, including North America, Europe, and Asia, leading in lung cancer screening initiatives and providing automated analysis and 3D visualization technologies to enhance diagnostic efficiency and accuracy for healthcare professionals.

Number of Employees

99people

Average Salary

65.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.434.0Point

PBR

3.04Industry Average 1.280.0Point

2.4x industry avg (risky)

ROE

-132.77Industry Average 1.360.0Point

Well below industry avg

Debt Ratio

9.38Industry Average 7.932.0Point

Higher than industry avg (caution)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲2.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼7.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -173.2% (improving, 3yr)

Detailed News Sentiment

7 totalPositive 1Neutral 1Negative 0Average Sentiment Score 85

Positive
코어라인소프트, 독일 샤리테 대학병원에 흉부진단 AI 공급
코어라인소프트가 독일 샤리테 대학병원에 흉부진단 AI 솔루션 '에이뷰(AVIEW) LCS Plus'를 공급하며 독일 국가 폐암검진 체계 주요 임상 거점에 진입했습니다.
Neutral
[바이오스냅] 메디톡스, 지방개선 주사제 '뉴비쥬' 출시
메디톡스의 지방개선 주사제 '뉴비쥬' 출시 소식으로, 코어라인소프트와 직접적인 관련은 없습니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 3,075Won52-week high 8,16052-week low 2,910

1-month return1.0Point

1m -7.66% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-09
Neutral전환사채(해외전환사채포함)발행후만기전사채취득2026-04-06
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral정기주주총회결과2026-03-27
Neutral사업보고서 (2025.12)2026-03-19